-
Feinberg Names 2024 Mentors of the Year
Feinberg’s Medical Faculty Council (MFC) honored the recipients of the 2024 Mentor of the Year awards at a workshop on May 29, with awardees sharing insights from their experiences mentoring students, trainees and peers.
-
First-Year Student Awarded for Human Brain-Computer Interface Research
Dillan Prasad, a first-year medical student at Feinberg, was recently recognized for outstanding research by the American Association of Neurological Surgeons.
-
Regenerating Damaged Heart Cells
Northwestern Medicine scientists have discovered a way to regenerate damaged heart muscle cells in mice, a development which may provide a new avenue for treating congenital heart defects, according to a study published in the Journal of Clinical Investigation.
-
Study Examines Surge in RSV Cases After the COVID-19 Pandemic
The surge in RSV cases following the COVID-19 pandemic may have been, in part, caused by increased testing and changes to the RSV genome, according to a Northwestern Medicine study published in Nature Communications.
-
New Genes Implicated in Multiple System Atrophy
A large international team of scientists have uncovered genetic risk factors for multiple system atrophy, according to a study published in Neuron.
-
New Biomarker May Predict Treatment Response in Bladder Cancer
Patients with metastatic urothelial cancer and increased expression of the NECTIN4 gene had a dramatically better response to antibody treatment than patients with reduced gene expression, according to recent findings published in the Journal of Clinical Oncology.
-
Improving Models to Study the Human Heart
Northwestern Medicine scientists have developed a new method of measuring and optimizing the maturation process of cultured heart cells, an approach that will set the future standard for a commonly used cell model in scientific research, according to details published in Cell Reports.
-
Gene Therapies Could Transform Treatment of Rare Blood Disorders
A new gene therapy could revolutionize treatment for two rare genetic blood disorders, according to a pair of trials published in the New England Journal of Medicine.
-
Children With Skin Diseases Suffer Stigma, Bullying and Depression
A study has shown the majority of children and teens with chronic skin diseases feel stigmatized by peers for their condition, are sometimes bullied, and often suffer from depression and anxiety.
-
Feinberg Faculty and Regulatory Affairs Welcomes New Senior Director
Joan Trimuel Williams has been named Feinberg’s senior director for Faculty and Regulatory Affairs.
-
Tech Can’t Replace Human Coaches in Obesity Treatment
In obesity treatments, patients who only received technology assistance were less likely to show weight loss than those who also received help from a human coach, according to a new study.
-
New Mechanisms Underlying Tumor Variety in Brain Cancers Discovered
Investigators have discovered new mechanisms underlying intratumor heterogeneity and treatment resistance in meningiomas, the most common type of primary central nervous system tumor, according to a recent study published in Nature Genetics.
-
Novel Genetic Mechanisms May Serve as Therapeutic Target Against Glioma
A recent study from the laboratory of Shi-Yuan Cheng, PhD, has identified novel mechanisms underlying RNA splicing events within glioma tumor cells, mechanisms which may serve as novel therapeutic targets, according to findings published in The Journal of Clinical Investigation.
-
Celebrating the MD Class of 2024
Feinberg honored the MD Class of 2024 during the medical school’s 165th commencement ceremony held in the Aon Grand Ballroom at Navy Pier on May 13.
-
Honors Day Recognizes Student and Faculty Excellence
Faculty members and fourth-year medical students were recognized for academic and clinical excellence during Feinberg’s Honors Day, held on May 10 in the Hughes auditorium.
-
Genetic Variation Linked to Increased Risk of Pick’s Disease
A unique genetic variation in the MAPT gene was associated with increased risk of Pick’s disease, a rare form of frontotemporal dementia, according to a recent study published in The Lancet Neurology.
-
Leading Prostate Cancer Research for More than 20 Years
Prostate cancer is the most common type of cancer in men and is currently the second-leading cause of death in men in the U.S. In 2001, the National Cancer Institute established seven Specialized Programs of Research Excellence (SPORE) in prostate cancer across the U.S., one of which includes the Robert H. Lurie Comprehensive Cancer Center…
-
How Herpes Hijacks a Ride into Cells
Northwestern Medicine scientists have discovered how herpes viruses hijack cellular transport processes to infiltrate the nervous system, according to a study published in the Proceedings of the National Academy of Sciences.
-
Weight Loss Drug Shows Benefits for Heart Failure
Semaglutide, sold under brand names Ozempic and Wegovy, can help reduce heart failure symptoms and reduce heart failure hospitalizations in patients with obesity, according to a pair of studies published in The Lancet and The New England Journal of Medicine.
-
Study Identifies Disparities in End-of-Life Care for Lung Cancer Patients
Patients with lung cancer who were Asian/Pacific Islander, Black or Hispanic experienced a higher intensity of end-of-life care compared to white patients, according to a Northwestern Medicine population-based analysis published in the Journal of Clinical Oncology.
